Clinical AI
When Perfect AI Scores Don't Translate to Better Patient Care: The Benchmark Illusion Unraveling Clinical AI
A landmark trial reveals that AI tools can ace every technical metric while delivering no measurable improvement in patient outcomes—forcing regulators and sponsors to rethink how clinical algorithms are validated.
Health AI Central Editorial Team·September 9, 2026
Drug Discovery & Research
Clinical Trial AI Delivers 82-Fold Return in Tufts Economic Model, But Humans Still Hold the Reins
New analysis quantifies up to $21 million in value from Medable's monitoring agent for phase 3 oncology trials, establishing the first major ROI benchmark as the industry moves from pilot programs to production deployment.
Health AI Central Editorial Team·August 27, 2026
Healthcare Operations
How a $2 Billion Acquisition Could End the Era of Fragmented Drug Safety Data
Dassault Systèmes' purchase of ArisGlobal aims to connect siloed healthcare systems and detect emerging drug risks before they reach patients.
Health AI Central Editorial Team·August 2, 2026
Drug Discovery & Research
Clinical Trial AI Gets a Major Overhaul as Medidata Bets on Platform Integration Over Point Solutions
New embedded AI layer aims to solve biopharma's fragmented tooling problem as industry leaders admit 71% of current AI deployments fall short of expectations.
Health AI Central Editorial Team·July 25, 2026